ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes
ImmunoHorizons · 2025
DOI: 10.1093/immhor/vlaf025 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Marc L Herman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO, United States. Hauptthemen laut MEDLINE: Intercellular Adhesion Molecule-1, Autoantibodies, Epitopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Children's Mercy Research Institute and Children's Mercy Kansas City, Children’s Mercy Research Institute and Children’s Mercy Kansas City.
Abstract (Originalsprache)
Intracellular adhesion molecule 1 (ICAM-1) is a cell surface glycoprotein that regulates cell-cell interactions, signaling, and immune processes. ICAM-1 expression has been shown to be elevated in many types of infections and inflammatory diseases. Strategies to block ICAM-1 function, including monoclonal anti-ICAM-1 antibodies, have been successful in treating the effects of chronic respiratory, autoimmune, and cardiovascular diseases. Naturally occurring autoantibodies targeting cytokines, endothelial cells, and other host receptors have been identified, and have been found to play a role in immunoregulation in health and disease. In this study, we determined the presence and levels of ICAM-1 autoantibodies across different age groups and disease states. We found that ICAM-1 autoantibody levels increased with age and were lower in individuals with various inflammatory states, suggesting a dynamic role in immune regulation. Using peptide microarrays, we identified high-resolution epitopes targeted by ICAM-1 autoantibodies that overlap with critical functional ICAM-1 binding sites. Finally, we determined that ICAM-1 autoantibodies were enriched for the IgG2 subclass that is critical for the response to bacterial antigens and chronic inflammation. This could indicate that molecular mimicry of bacterial antigens or underlying immune dysregulation could trigger the generation of anti-ICAM-1 antibodies. Understanding the functional implications of ICAM-1 autoantibodies could provide new insights into their contribution to immune homeostasis and their potential impact on inflammatory and autoimmune conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO, United States.
- University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States.
- College of Osteopathic Medicine, Kansas City University, Kansas City, MO, United States.
- Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO, United States.
- Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS, United States.
- Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States.
Förderung
- Children's Mercy Research Institute and Children's Mercy Kansas City
- Children’s Mercy Research Institute and Children’s Mercy Kansas City
Zitieren
APA
Herman, M. L., Geanes, E. S., McLennan, R., Greening, G. J., Mwitanti, H., & Bradley, T. (2025). ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf025
Vancouver
Herman ML, Geanes ES, McLennan R, Greening GJ, Mwitanti H, Bradley T. ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes. ImmunoHorizons. 2025. doi:10.1093/immhor/vlaf025
BibTeX
@article{Herman2025,
author = {Herman, Marc L and Geanes, Eric S and McLennan, Rebecca and Greening, Gage J and Mwitanti, Heather and Bradley, Todd},
title = {ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes},
journal = {ImmunoHorizons},
year = {2025},
doi = {10.1093/immhor/vlaf025}
}
EUVIMED